189 related articles for article (PubMed ID: 18209065)
41. Cloning, genomic organization, alternative transcripts and expression analysis of CD99L2, a novel paralog of human CD99, and identification of evolutionary conserved motifs.
Suh YH; Shin YK; Kook MC; Oh KI; Park WS; Kim SH; Lee IS; Park HJ; Huh TL; Park SH
Gene; 2003 Mar; 307():63-76. PubMed ID: 12706889
[TBL] [Abstract][Full Text] [Related]
42. NKR-P1A protein, an activating receptor of rat natural killer cells, binds to the chitobiose core of uncompletely glycosylated N-linked glycans, and to linear chitooligomers.
Bezouska K; Sklenár J; Dvoráková J; Havlícek V; Pospísil M; Thiem J; Kren V
Biochem Biophys Res Commun; 1997 Sep; 238(1):149-53. PubMed ID: 9299469
[TBL] [Abstract][Full Text] [Related]
43. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D
Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997
[TBL] [Abstract][Full Text] [Related]
44. A novel CD8 T cell-restricted CD45RB epitope shared by CD43 is differentially affected by glycosylation.
Carlow DA; Ardman B; Ziltener HJ
J Immunol; 1999 Aug; 163(3):1441-8. PubMed ID: 10415045
[TBL] [Abstract][Full Text] [Related]
45. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.
Brockhausen I; Dowler T; Paulsen H
Biochim Biophys Acta; 2009 Oct; 1790(10):1244-57. PubMed ID: 19524017
[TBL] [Abstract][Full Text] [Related]
46. Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells.
Colonna M; Nakajima H; Cella M
J Leukoc Biol; 1999 Nov; 66(5):718-22. PubMed ID: 10577499
[TBL] [Abstract][Full Text] [Related]
47. Enhanced recognition of human NK receptors after influenza virus infection.
Achdout H; Arnon TI; Markel G; Gonen-Gross T; Katz G; Lieberman N; Gazit R; Joseph A; Kedar E; Mandelboim O
J Immunol; 2003 Jul; 171(2):915-23. PubMed ID: 12847262
[TBL] [Abstract][Full Text] [Related]
48. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake.
Jones C; Virji M; Crocker PR
Mol Microbiol; 2003 Sep; 49(5):1213-25. PubMed ID: 12940982
[TBL] [Abstract][Full Text] [Related]
49. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49.
McVicar DW; Burshtyn DN
Sci STKE; 2001 Mar; 2001(75):re1. PubMed ID: 11752646
[TBL] [Abstract][Full Text] [Related]
50. Chicken NK cell receptors.
Straub C; Neulen ML; Sperling B; Windau K; Zechmann M; Jansen CA; Viertlboeck BC; Göbel TW
Dev Comp Immunol; 2013 Nov; 41(3):324-33. PubMed ID: 23542703
[TBL] [Abstract][Full Text] [Related]
51. Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.
Mathew SO; Kumaresan PR; Lee JK; Huynh VT; Mathew PA
J Immunol; 2005 Jul; 175(2):1005-13. PubMed ID: 16002700
[TBL] [Abstract][Full Text] [Related]
52. SHP-1/immunoreceptor tyrosine-based inhibition motif-independent inhibitory signalling through murine natural killer cell receptor Ly-49A in a transfected B-cell line.
Motoda K; Takata M; Kiura K; Nakamura I; Harada M
Immunology; 2000 Jul; 100(3):370-7. PubMed ID: 10929060
[TBL] [Abstract][Full Text] [Related]
53. A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice.
Furukawa H; Iizuka K; Poursine-Laurent J; Shastri N; Yokoyama WM
J Immunol; 2002 Jul; 169(1):126-36. PubMed ID: 12077237
[TBL] [Abstract][Full Text] [Related]
54. The murine CD99-related molecule CD99-like 2 (CD99L2) is an adhesion molecule involved in the inflammatory response.
Schenkel AR; Dufour EM; Chew TW; Sorg E; Muller WA
Cell Commun Adhes; 2007; 14(5):227-37. PubMed ID: 18163232
[TBL] [Abstract][Full Text] [Related]
55. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies.
Sivori S; Vitale M; Bottino C; Marcenaro E; Sanseverino L; Parolini S; Moretta L; Moretta A
Eur J Immunol; 1996 Oct; 26(10):2487-92. PubMed ID: 8898964
[TBL] [Abstract][Full Text] [Related]
56. Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors.
Warren HS; Campbell AJ; Waldron JC; Lanier LL
Int Immunol; 2001 Aug; 13(8):1043-52. PubMed ID: 11470774
[TBL] [Abstract][Full Text] [Related]
57. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits.
Lazetic S; Chang C; Houchins JP; Lanier LL; Phillips JH
J Immunol; 1996 Dec; 157(11):4741-5. PubMed ID: 8943374
[TBL] [Abstract][Full Text] [Related]
58. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
[TBL] [Abstract][Full Text] [Related]
59. Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.
Welch AY; Kasahara M; Spain LM
Immunogenetics; 2003 Feb; 54(11):782-90. PubMed ID: 12618911
[TBL] [Abstract][Full Text] [Related]
60. Solution structure of the cytoplasmic domain of human CD99 type I.
Kim HY; Kim YM; Shin YK; Park SH; Lee W
Mol Cells; 2004 Aug; 18(1):24-9. PubMed ID: 15359120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
